Generic Combination Products: Assessment and Regulatory Update (14of16) GDF 2020

array(10) { [0]=> object(stdClass)#7550 (5) { ["video_id"]=> int(9999999) ["related_video_id"]=> string(11) "edZXVpcpcas" ["related_video_title"]=> string(86) "Facility Readiness: GMPs, Quality Assessments, and Compliance Trends (15of16) GDF 2020" ["posted_time"]=> string(19) "5 лет назад" ["channelName"]=> string(33) "U.S. Food and Drug Administration" } [1]=> object(stdClass)#7523 (5) { ["video_id"]=> int(9999999) ["related_video_id"]=> string(11) "TNDEdicVWB8" ["related_video_title"]=> string(81) "Navigating the World of Combination Products (2of15) REdI – May 29-30, 2019" ["posted_time"]=> string(19) "5 лет назад" ["channelName"]=> string(33) "U.S. Food and Drug Administration" } [2]=> object(stdClass)#7548 (5) { ["video_id"]=> int(9999999) ["related_video_id"]=> string(11) "IAJQqQ3oVpE" ["related_video_title"]=> string(30) "Is My Product A Medical Device" ["posted_time"]=> string(21) "4 года назад" ["channelName"]=> string(33) "U.S. Food and Drug Administration" } [3]=> object(stdClass)#7555 (5) { ["video_id"]=> int(9999999) ["related_video_id"]=> string(11) "NrQOcveT8B4" ["related_video_title"]=> string(100) "GDF2025-D2S08-Common Clinical Deficiencies in ANDAs Containing Comparative Clinical Endpoint Studies" ["posted_time"]=> string(21) "5 дней назад" ["channelName"]=> string(33) "U.S. Food and Drug Administration" } [4]=> object(stdClass)#7534 (5) { ["video_id"]=> int(9999999) ["related_video_id"]=> string(11) "SdgcMOCI-sI" ["related_video_title"]=> string(45) "GDF2025 - D2S02- Nitrosamine Related Guidance" ["posted_time"]=> string(21) "5 дней назад" ["channelName"]=> string(33) "U.S. Food and Drug Administration" } [5]=> object(stdClass)#7552 (5) { ["video_id"]=> int(9999999) ["related_video_id"]=> string(11) "1l4nmalycoU" ["related_video_title"]=> string(73) "Generic Drug Product Quality Assessment (22of27) Generic Drugs Forum 2018" ["posted_time"]=> string(19) "5 лет назад" ["channelName"]=> string(33) "U.S. Food and Drug Administration" } [6]=> object(stdClass)#7547 (5) { ["video_id"]=> int(9999999) ["related_video_id"]=> string(11) "pDImqkPHNYs" ["related_video_title"]=> string(93) "GDF2025 - D2S01- General Quality Considerations of Drug Products Labeled for Alternate Dosing" ["posted_time"]=> string(21) "5 дней назад" ["channelName"]=> string(33) "U.S. Food and Drug Administration" } [7]=> object(stdClass)#7557 (5) { ["video_id"]=> int(9999999) ["related_video_id"]=> string(11) "97yEaDJDxKo" ["related_video_title"]=> string(41) "Overview of the Quality System Regulation" ["posted_time"]=> string(21) "4 года назад" ["channelName"]=> string(33) "U.S. Food and Drug Administration" } [8]=> object(stdClass)#7533 (5) { ["video_id"]=> int(9999999) ["related_video_id"]=> string(11) "IKA2wv4itvo" ["related_video_title"]=> string(95) "Improving the Sterility Assurance Application to the FDA – Generic Drugs Forum (GDF) 2024" ["posted_time"]=> string(28) "11 месяцев назад" ["channelName"]=> string(33) "U.S. Food and Drug Administration" } [9]=> object(stdClass)#7551 (5) { ["video_id"]=> int(9999999) ["related_video_id"]=> string(11) "LHqWOmlHth0" ["related_video_title"]=> string(83) "GDF2025 - D1S20 - Questions & Panel Discussion - Session Four / Day One Closing" ["posted_time"]=> string(21) "5 дней назад" ["channelName"]=> string(33) "U.S. Food and Drug Administration" } }